Results 21 to 30 of about 3,242,059 (273)

Tumor Markers in Dogs with Mammary Gland Tumors

Acta Veterinaria, 2023
The aim of this study was to determine and compare values of carcinoembryonic antigen (CEA) and cancer antigen (CA 15-3) in 50 bitches with mammary tumors and 150 clinically healthy dogs.
Valencakova Alexandra, Kiselova-Bilekova Beata, Figurova Maria, Hornak Slavomir, Hornakova Lubica   +4 more
doaj   +1 more source

Performance Characteristics of Seven Automated CA 15-3 Assays [PDF]

American Journal of Clinical Pathology, 2006
Measurements of serum cancer antigen (CA) 15-3 are used to monitor tumor recurrence and treatment of advanced disease. We evaluated the performance characteristics, including limit of detection, linearity, method comparison, and reference intervals, of 7 automated methods for CA 15-3, including the Access 2 (Beckman Coulter, Brea, CA), ADVIA Centaur ...
Patricia R, Slev, Mindy L, Rawlins, William L, Roberts   +2 more
openaire   +2 more sources

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

BMC Cancer, 2012
Background Mucin-1 is known to be over-expressed by various human carcinomas and is shed into the circulation where it can be detected in patient’s serum by specific anti-Mucin-1 antibodies, such as the tumour marker assays CA 15–3 and CA 27.29.
Engelstaedter Verena, Heublein Sabine, Schumacher Anamur Lan, Lenhard Miriam, Engelstaedter Helen, Andergassen Ulrich, Guenthner-Biller Margit, Kuhn Christina, Rack Brigitte, Kupka Markus, Mayr Doris, Jeschke Udo   +11 more
doaj   +1 more source

Gene expression of Epithelial Membrane Protein 2 gene and β1-Integrin gene in patients with breast cancer

Biochemistry and Biophysics Reports, 2020
Background: Breast cancer is the most common invasive cancer and the leading cause of cancer death in women. The function of over a thousand genes is reported as affected by genetic modifications in breast cancer. Objectives: To study the gene expression
Samah EL-Ghlban, Elsayed Saber AbouElnour, Abd El-Monem Abd El- Kader EL- Torgoman, Saeed Mohamed Saeed Abu Elabas   +3 more
doaj   +1 more source

Investigation of a Stable Interaction of Levothyroxine with AFP Through Molecular Modelling

Cumhuriyet Science Journal
Thyroid dysfunctions are common all over the world, and accordingly, the use of thyroid drugs has increased. Incorrect measurement of tumor markers may lead to missed cases of cancer.
Emel Akbaba, Deniz Karataş, Ataman Gönel, Ezgi Soylu, Beste Kiraz, Yusur Ammar Almahdi   +5 more
doaj   +1 more source

Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1999
A retrospective clinical study was conducted to compare results obtained by AxSYM(R) CA 15-3(TM), IMx(R) CA 15-3 and Truquant(R) BRTM RIA using surplus serum specimens from healthy volunteers and patients with benign and malignant diseases. Linear regression analysis of AxSYM and IMx CA 15-3 versus Truquant BR RIA for specimens with results 0-250 U/ml ...
D M, Lynch, P E, Rogers, J C, Love, M J, Salkas, K A, Skarphol, M E, Gross, M G, Lu, V H, Petrides, D J, Bruzek, J L, Cox, K A, Jones, C A, Kelley, D W, Chan   +12 more
openaire   +2 more sources

Multicenter evaluation of the Abbott IMx CA 15-3 assay [PDF]

Clinical Chemistry, 1996
Abstract We describe a new fully automated procedure for the quantitative measurement of CA 15-3: the microparticle enzyme immunoassay (MEIA) technology developed by Abbott Labs. for the IMx automated immunoassay analyzer. The new IMx CA 15-3 test uses two mouse monoclonal antibodies, 115D8 and DF3.
G J, van Kamp, G G, Bon, R A, Verstraeten, D, Lynch, M, Krikau, J, Flückiger, A, Ruibal, P, Kenemans   +7 more
openaire   +2 more sources

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Sensitivity and Specificity of CA 15-3 in Detection of Breast Cancer Recurrence [PDF]

Journal of Kerman University of Medical Sciences, 2005
Background: The value of CA15-3(cancer antigen 15-3) marker in early detection of breast cancer recurrence has been studied in several prospective trials. But the results of these studies are different.
Sh. Omidvari, D Moslemi, A Mosalaei, M Mohamadian Panah, N Ahmadloo   +4 more
doaj  

Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results

Consilium Medicum, 2023
Aim. Demonstration the possibility of practical application of the highly sensitive tumor marker CA-62 in the initial diagnosis in asymptomatic patients with suspected cancer and/or the presence of pathological changes in instrumental studies, as well as
Janneta R. Tcherkassova, Sergei A. Tsurkan, Anna I. Prostyakova, Nikolai V. Suganov, Alexander M. Boroda, Albina I. Khamitova, Alexander P. Roytman   +6 more
doaj   +1 more source